{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:45:49Z","timestamp":1785825949549,"version":"3.56.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012521","name":"Universitas Gadjah Mada","doi-asserted-by":"publisher","award":["431\/UN1.P1\/KPT\/HUKOR\/2024"],"award-info":[{"award-number":["431\/UN1.P1\/KPT\/HUKOR\/2024"]}],"id":[{"id":"10.13039\/501100012521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12455-w","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:06:53Z","timestamp":1785823613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological evaluation reveals distinct anti-proliferative and migration-associated effects of curcumin analogues B-143 and B-155 in ovarian cancer cells"],"prefix":"10.1007","volume":"53","author":[{"given":"Retno","family":"Murwanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalina","family":"Diani Prima Anargya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakti Wahyu","family":"Saputra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhra Nur Jauza","family":"Ozura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadzifa","family":"Nugraheni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisca","family":"Ucche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navista","family":"Sri Octa Ujiantari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritmaleni","family":"Ritmaleni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agung Endro","family":"Nugroho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"12455_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"key":"12455_CR2","unstructured":"World Cancer Research Fund International (2024) Ovarian cancer statistics. https:\/\/www.wcrf.org\/preventing-cancer\/cancer-statistics\/ovarian-cancer-statistics\/. Accessed 6 Aug 2025"},{"key":"12455_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2025.15130","volume":"30","author":"K Alrosan","year":"2025","unstructured":"Alrosan K, Alrosan A, Heilat G et al (2025) Treatment of ovarian cancer: From the past to the new era (Review). Oncol Lett 30:1\u201328. https:\/\/doi.org\/10.3892\/ol.2025.15130","journal-title":"Oncol Lett"},{"key":"12455_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41698-025-00874-0","volume":"9","author":"TJ Herzog","year":"2025","unstructured":"Herzog TJ, Krivak TC, Bush S et al (2025) ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial. NPJ Precis Oncol 9:86. https:\/\/doi.org\/10.1038\/s41698-025-00874-0","journal-title":"NPJ Precis Oncol"},{"key":"12455_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41419-023-05859-0","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang S, Liu Q, Chang M et al (2023) Chemotherapy impairs ovarian function through excessive ROS-induced ferroptosis. Cell Death Dis 14:340. https:\/\/doi.org\/10.1038\/s41419-023-05859-0","journal-title":"Cell Death Dis"},{"key":"12455_CR6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.30968\/rbfhss.2022.133.0823","volume":"13","author":"TA Gouv\u00eaa","year":"2022","unstructured":"Gouv\u00eaa TA, Chaves GV, Sobreira-DA-Silva MJ (2022) An\u00e1lise de toxicidades relacionadas ao protocolo carboplatina e paclitaxel em pacientes com c\u00e2ncer de ov\u00e1rio. Revista Brasileira de Farm\u00e1cia Hospitalar e Servi\u00e7os de Sa\u00fade 13:823. https:\/\/doi.org\/10.30968\/rbfhss.2022.133.0823","journal-title":"Revista Brasileira de Farm\u00e1cia Hospitalar e Servi\u00e7os de Sa\u00fade"},{"key":"12455_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/curroncol31010007","volume":"31","author":"S Moufarrij","year":"2023","unstructured":"Moufarrij S, O\u2019Cearbhaill RE (2023) Novel Therapeutics in Ovarian Cancer: Expanding the Toolbox. Curr Oncol 31:97\u2013114. https:\/\/doi.org\/10.3390\/curroncol31010007","journal-title":"Curr Oncol"},{"key":"12455_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3390\/cells13070611","volume":"13","author":"S Frezzini","year":"2024","unstructured":"Frezzini S, Lonardi S (2024) Spotlight on New Hallmarks of Drug-Resistance towards Personalized Care for Epithelial Ovarian Cancer. Cells 13:611. https:\/\/doi.org\/10.3390\/cells13070611","journal-title":"Cells"},{"key":"12455_CR9","doi-asserted-by":"publisher","unstructured":"Cozmin M, Lungu II, Gutu C et al (2024) Turmeric: from spice to cure. A review of the anti-cancer, radioprotective and anti-inflammatory effects of turmeric sourced compounds. Front Nutr 11. https:\/\/doi.org\/10.3389\/fnut.2024.1399888","DOI":"10.3389\/fnut.2024.1399888"},{"key":"12455_CR10","doi-asserted-by":"publisher","unstructured":"Ameer SF, Mohamed MY, Elzubair QA et al (2024) Curcumin as a novel therapeutic candidate for cancer: can this natural compound revolutionize cancer treatment? Front Oncol 14. https:\/\/doi.org\/10.3389\/fonc.2024.1438040","DOI":"10.3389\/fonc.2024.1438040"},{"key":"12455_CR11","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.13005\/bpj\/3012","volume":"17","author":"H Sasongko","year":"2024","unstructured":"Sasongko H, Maharani AH, Hutasoit JA et al (2024) An Updated Review of Curcumin in Health Applications: In-vivo Studies and Clinical Trials. Biomedical Pharmacol J 17:2135\u20132145. https:\/\/doi.org\/10.13005\/bpj\/3012","journal-title":"Biomedical Pharmacol J"},{"key":"12455_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/ph17020164","volume":"17","author":"V Bu\u010devi\u0107 Popovi\u0107","year":"2024","unstructured":"Bu\u010devi\u0107 Popovi\u0107 V, Karahmet Farhat E, Banjari I et al (2024) Bioavailability of Oral Curcumin in Systematic Reviews: A Methodological Study. Pharmaceuticals 17:164. https:\/\/doi.org\/10.3390\/ph17020164","journal-title":"Pharmaceuticals"},{"key":"12455_CR13","doi-asserted-by":"publisher","first-page":"115079","DOI":"10.1016\/j.foodres.2024.115079","volume":"196","author":"J Zhao","year":"2024","unstructured":"Zhao J, Jia W, Zhang R et al (2024) Improving curcumin bioavailability: Targeted delivery of curcumin and loading systems in intestinal inflammation. Food Res Int 196:115079. https:\/\/doi.org\/10.1016\/j.foodres.2024.115079","journal-title":"Food Res Int"},{"key":"12455_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.7150\/jca.49406","volume":"12","author":"V Gogineni","year":"2021","unstructured":"Gogineni V, Morand S, Staats H et al (2021) Current Ovarian Cancer Maintenance Strategies and Promising New Developments. J Cancer 12:38\u201353. https:\/\/doi.org\/10.7150\/jca.49406","journal-title":"J Cancer"},{"key":"12455_CR15","first-page":"9","volume":"39","author":"Ritmaleni","year":"2016","unstructured":"Ritmaleni (2016) Synthesis of pentagamavunon-0 (PGV-0): An improved technique. Int J Pharm Sci Rev Res 39:9\u201311","journal-title":"Int J Pharm Sci Rev Res"},{"key":"12455_CR16","doi-asserted-by":"publisher","first-page":"14867","DOI":"10.1038\/s41598-019-51244-3","volume":"9","author":"B Lestari","year":"2019","unstructured":"Lestari B, Nakamae I, Yoneda-Kato N et al (2019) Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence. Sci Rep 9:14867. https:\/\/doi.org\/10.1038\/s41598-019-51244-3","journal-title":"Sci Rep"},{"key":"12455_CR17","doi-asserted-by":"publisher","first-page":"100230","DOI":"10.1016\/j.crtox.2025.100230","volume":"8","author":"R Murwanti","year":"2025","unstructured":"Murwanti R, Ritmaleni, Ujiantari NSO et al (2025) Bioinformatics study and cytotoxicity of several curcumin analogues in ovarian cancer. Curr Res Toxicol 8:100230. https:\/\/doi.org\/10.1016\/j.crtox.2025.100230","journal-title":"Curr Res Toxicol"},{"key":"12455_CR18","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V (2019) SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47:W357\u2013W364. https:\/\/doi.org\/10.1093\/nar\/gkz382","journal-title":"Nucleic Acids Res"},{"key":"12455_CR19","doi-asserted-by":"publisher","first-page":"W726","DOI":"10.1093\/nar\/gkac297","volume":"50","author":"K Gallo","year":"2022","unstructured":"Gallo K, Goede A, Preissner R, Gohlke B-O (2022) SuperPred 3.0: drug classification and target prediction\u2014a machine learning approach. Nucleic Acids Res 50:W726\u2013W731. https:\/\/doi.org\/10.1093\/nar\/gkac297","journal-title":"Nucleic Acids Res"},{"key":"12455_CR20","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.3390\/ijms22052622","volume":"22","author":"\u00c1 Bartha","year":"2021","unstructured":"Bartha \u00c1, Gy\u0151rffy B (2021) TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues. Int J Mol Sci 22:2622. https:\/\/doi.org\/10.3390\/ijms22052622","journal-title":"Int J Mol Sci"},{"key":"12455_CR21","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M et al (2023) The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51:D638\u2013D646. https:\/\/doi.org\/10.1093\/nar\/gkac1000","journal-title":"Nucleic Acids Res"},{"key":"12455_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1021\/acs.jproteome.2c00651","volume":"22","author":"NT Doncheva","year":"2023","unstructured":"Doncheva NT, Morris JH, Holze H et al (2023) Cytoscape stringApp 2.0: Analysis and Visualization of Heterogeneous Biological Networks. J Proteome Res 22:637\u2013646. https:\/\/doi.org\/10.1021\/acs.jproteome.2c00651","journal-title":"J Proteome Res"},{"key":"12455_CR23","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s00404-019-05058-3","volume":"299","author":"L Liu","year":"2019","unstructured":"Liu L, Pang Y, Zhao X et al (2019) Curcumin induces apoptotic cell death and protective autophagy by inhibiting AKT\/mTOR\/p70S6K pathway in human ovarian cancer cells. Arch Gynecol Obstet 299:1627\u20131639. https:\/\/doi.org\/10.1007\/s00404-019-05058-3","journal-title":"Arch Gynecol Obstet"},{"key":"12455_CR24","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of Curcumin: Problems and Promises. Mol Pharm 4:807\u2013818. https:\/\/doi.org\/10.1021\/mp700113r","journal-title":"Mol Pharm"},{"key":"12455_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.18585\/inabj.v17i1.3431","volume":"17","author":"DR Rahmawati","year":"2025","unstructured":"Rahmawati DR, Meiyanto E, Jenie RI, Nurrochmad A (2025) Curcumin Enhances Antimigration of Pentagamavunon-1 by Suppressing MMP-2 and MMP-9 Expression in Triple-Negative (4T1) and Luminal A (T47D) Breast Cancer Cells. Indonesian Biomedical J 17:34\u201342. https:\/\/doi.org\/10.18585\/inabj.v17i1.3431","journal-title":"Indonesian Biomedical J"},{"key":"12455_CR26","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.7150\/ijbs.33710","volume":"15","author":"M Wang","year":"2019","unstructured":"Wang M, Jiang S, Zhou L et al (2019) Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs. Int J Biol Sci 15:1200\u20131214. https:\/\/doi.org\/10.7150\/ijbs.33710","journal-title":"Int J Biol Sci"},{"key":"12455_CR27","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.7150\/jca.45176","volume":"11","author":"T Wang","year":"2020","unstructured":"Wang T, Wu X, Al rudaisat M et al (2020) Curcumin induces G2\/M arrest and triggers autophagy, ROS generation and cell senescence in cervical cancer cells. J Cancer 11:6704\u20136715. https:\/\/doi.org\/10.7150\/jca.45176","journal-title":"J Cancer"},{"key":"12455_CR28","doi-asserted-by":"publisher","first-page":"50747","DOI":"10.18632\/oncotarget.17096","volume":"8","author":"A Hu","year":"2017","unstructured":"Hu A, Huang J-J, Zhang J-F et al (2017) Curcumin induces G2\/M cell cycle arrest and apoptosis of head and neck squamous cell carcinoma in vitro and in vivo through ATM\/Chk2\/p53-dependent pathway. Oncotarget 8:50747\u201350760. https:\/\/doi.org\/10.18632\/oncotarget.17096","journal-title":"Oncotarget"},{"key":"12455_CR29","first-page":"2024","volume":"8","author":"CG Ferreira","year":"2002","unstructured":"Ferreira CG, Epping M, Kruyt FAE, Giaccone G (2002) Apoptosis: target of cancer therapy. Clin Cancer Res 8:2024\u20132034","journal-title":"Clin Cancer Res"},{"key":"12455_CR30","first-page":"1391","volume":"59","author":"JM Brown","year":"1999","unstructured":"Brown JM, Wouters BG (1999) Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 59:1391\u20131399","journal-title":"Cancer Res"},{"key":"12455_CR31","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.5114\/aoms.2017.66747","volume":"6","author":"W Feng","year":"2017","unstructured":"Feng W, Li L, Xu X et al (2017) Up-regulation of the long non-coding RNA RMRP contributes to glioma progression and promotes glioma cell proliferation and invasion. Archives Med Sci 6:1315\u20131321. https:\/\/doi.org\/10.5114\/aoms.2017.66747","journal-title":"Archives Med Sci"},{"key":"12455_CR32","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3892\/ijo.2020.5065","volume":"57","author":"F Mohammed","year":"2020","unstructured":"Mohammed F, Rashid-Doubell F, Taha S et al (2020) Effects of curcumin complexes on MDA-MB-231 breast cancer cell proliferation. Int J Oncol 57:445\u2013455. https:\/\/doi.org\/10.3892\/ijo.2020.5065","journal-title":"Int J Oncol"},{"key":"12455_CR33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.14499\/indonesianjcanchemoprev10iss3pp114-121","volume":"10","author":"SM Angraini","year":"2019","unstructured":"Angraini SM, Nugraheni N, Meiyanto E, Hermawan A (2019) Analog Curcumin, Pentagamavunon-0 (PGV-0), Induces Senescence and Increases Cytotoxic Effect of Doxorubicin on HCC 1954 Cells. Indonesian J Cancer Chemoprevention 10:114. https:\/\/doi.org\/10.14499\/indonesianjcanchemoprev10iss3pp114-121","journal-title":"Indonesian J Cancer Chemoprevention"},{"key":"12455_CR34","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2018.4295","author":"W Li","year":"2018","unstructured":"Li W, Jiang Z, Xiao X et al (2018) Curcumin inhibits superoxide dismutase-induced epithelial-to-mesenchymal transition via the PI3K\/Akt\/NF-\u03baB pathway in pancreatic cancer cells. Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2018.4295","journal-title":"Int J Oncol"},{"key":"12455_CR35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.15171\/apb.2019.053","volume":"9","author":"E Meiyanto","year":"2019","unstructured":"Meiyanto E, Putri H, Arum Larasati Y et al (2019) Anti-proliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation. Adv Pharm Bull 9:445\u2013452. https:\/\/doi.org\/10.15171\/apb.2019.053","journal-title":"Adv Pharm Bull"},{"key":"12455_CR36","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.3390\/ijms23052496","volume":"23","author":"JR Wilczy\u0144ski","year":"2022","unstructured":"Wilczy\u0144ski JR, Wilczy\u0144ski M, Paradowska E (2022) Cancer Stem Cells in Ovarian Cancer\u2014A Source of Tumor Success and a Challenging Target for Novel Therapies. Int J Mol Sci 23:2496. https:\/\/doi.org\/10.3390\/ijms23052496","journal-title":"Int J Mol Sci"},{"key":"12455_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/PPO.0000000000000138","volume":"21","author":"DR Bielenberg","year":"2015","unstructured":"Bielenberg DR, Zetter BR (2015) The Contribution of Angiogenesis to the Process of Metastasis. Cancer J 21:267\u2013273. https:\/\/doi.org\/10.1097\/PPO.0000000000000138","journal-title":"Cancer J"},{"key":"12455_CR38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41392-024-01885-2","volume":"9","author":"X Shi","year":"2024","unstructured":"Shi X, Wang X, Yao W et al (2024) Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives. Signal Transduct Target Ther 9:192. https:\/\/doi.org\/10.1038\/s41392-024-01885-2","journal-title":"Signal Transduct Target Ther"},{"key":"12455_CR39","doi-asserted-by":"publisher","unstructured":"Haibe Y, Kreidieh M, El Hajj H et al (2020) Resistance Mechanisms to Anti-angiogenic Therapies in Cancer. Front Oncol 10. https:\/\/doi.org\/10.3389\/fonc.2020.00221","DOI":"10.3389\/fonc.2020.00221"},{"key":"12455_CR40","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.3390\/cancers15092485","volume":"15","author":"D Standing","year":"2023","unstructured":"Standing D, Feess E, Kodiyalam S et al (2023) The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy. Cancers (Basel) 15:2485. https:\/\/doi.org\/10.3390\/cancers15092485","journal-title":"Cancers (Basel)"},{"key":"12455_CR41","doi-asserted-by":"publisher","unstructured":"Ma Y-T, Li C, Shen Y et al (2025) Mechanisms of the JNK\/p38 MAPK signaling pathway in drug resistance in ovarian cancer. Front Oncol 15. https:\/\/doi.org\/10.3389\/fonc.2025.1533352","DOI":"10.3389\/fonc.2025.1533352"},{"key":"12455_CR42","doi-asserted-by":"publisher","unstructured":"Shi Y, Riese DJ, Shen J (2020) The Role of the CXCL12\/CXCR4\/CXCR7 Chemokine Axis in Cancer. Front Pharmacol 11. https:\/\/doi.org\/10.3389\/fphar.2020.574667","DOI":"10.3389\/fphar.2020.574667"},{"key":"12455_CR43","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1021\/acsptsci.4c00518","volume":"7","author":"K Vesel\u00e1","year":"2024","unstructured":"Vesel\u00e1 K, Kej\u00edk Z, Masa\u0159\u00edk M et al (2024) Curcumin: A Potential Weapon in the Prevention and Treatment of Head and Neck Cancer. ACS Pharmacol Transl Sci 7:3394\u20133418. https:\/\/doi.org\/10.1021\/acsptsci.4c00518","journal-title":"ACS Pharmacol Transl Sci"},{"key":"12455_CR44","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s10147-025-02782-6","volume":"30","author":"MV Shahana","year":"2025","unstructured":"Shahana MV, Choudhary B (2025) HSP90 and the cancer transcriptome: a comprehensive review of inhibitors and mechanistic insights. Int J Clin Oncol 30:1294\u20131308. https:\/\/doi.org\/10.1007\/s10147-025-02782-6","journal-title":"Int J Clin Oncol"},{"key":"12455_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2018.03.024","volume":"425","author":"X Hu","year":"2018","unstructured":"Hu X, Mei S, Meng W et al (2018) CXCR4-mediated signaling regulates autophagy and influences acute myeloid leukemia cell survival and drug resistance. Cancer Lett 425:1\u201312. https:\/\/doi.org\/10.1016\/j.canlet.2018.03.024","journal-title":"Cancer Lett"},{"key":"12455_CR46","doi-asserted-by":"publisher","unstructured":"Delazer I, Bauer I, Rummel T et al (2025) Correction to \u2018mRNA turnover dynamics are affected by cell differentiation and loss of the cytosine methyltransferase Nsun2\u2019. Nucleic Acids Res 53. https:\/\/doi.org\/10.1093\/nar\/gkaf1375","DOI":"10.1093\/nar\/gkaf1375"},{"key":"12455_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11033-012-1930-3","volume":"40","author":"S Chu","year":"2013","unstructured":"Chu S, Liu Y, Zhang L et al (2013) Regulation of survival and chemoresistance by HSP90AA1 in ovarian cancer SKOV3 cells. Mol Biol Rep 40:1\u20136. https:\/\/doi.org\/10.1007\/s11033-012-1930-3","journal-title":"Mol Biol Rep"},{"key":"12455_CR48","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1142\/S2737416526500079","volume":"25","author":"S Tabrez","year":"2026","unstructured":"Tabrez S, Suhail M, Zaidi SK et al (2026) Network Pharmacology-guided Identification of Therapeutic Targets and Pathways for Cancer Stem Cell Inhibition Across Multiple Cancer Types. J Comput Biophys Chem 25:2229\u20132248. https:\/\/doi.org\/10.1142\/S2737416526500079","journal-title":"J Comput Biophys Chem"},{"key":"12455_CR49","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00432-014-1840-y","volume":"141","author":"D Nantajit","year":"2015","unstructured":"Nantajit D, Lin D, Li JJ (2015) The network of epithelial\u2013mesenchymal transition: potential new targets for tumor resistance. J Cancer Res Clin Oncol 141:1697\u20131713. https:\/\/doi.org\/10.1007\/s00432-014-1840-y","journal-title":"J Cancer Res Clin Oncol"},{"key":"12455_CR50","doi-asserted-by":"publisher","unstructured":"Liu H, Li Z, Xu B et al (2024) Curcumin suppresses metastasis, invasion, and proliferation in osteosarcoma cells by regulating the EGFR\/Src signaling axis. Int J Immunopathol Pharmacol 38. https:\/\/doi.org\/10.1177\/03946320241308082","DOI":"10.1177\/03946320241308082"},{"key":"12455_CR51","doi-asserted-by":"publisher","first-page":"110151","DOI":"10.1016\/j.cellsig.2021.110151","volume":"87","author":"D Singh","year":"2021","unstructured":"Singh D, Deshmukh RK, Das A (2021) SNAI1-mediated transcriptional regulation of epithelial-to-mesenchymal transition genes in breast cancer stem cells. Cell Signal 87:110151. https:\/\/doi.org\/10.1016\/j.cellsig.2021.110151","journal-title":"Cell Signal"},{"key":"12455_CR52","doi-asserted-by":"publisher","unstructured":"Jin A, Zhang C, Zheng W et al (2022) CD155\/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis. Clin Transl Med 12. https:\/\/doi.org\/10.1002\/ctm2.794","DOI":"10.1002\/ctm2.794"},{"key":"12455_CR53","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.4049\/jimmunol.173.2.1313","volume":"173","author":"M Bouaouina","year":"2004","unstructured":"Bouaouina M, Blouin E, Halbwachs-Mecarelli L et al (2004) TNF-Induced \u03b22 Integrin Activation Involves Src Kinases and a Redox-Regulated Activation of p38 MAPK. J Immunol 173:1313\u20131320. https:\/\/doi.org\/10.4049\/jimmunol.173.2.1313","journal-title":"J Immunol"},{"key":"12455_CR54","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/1753425916632305","volume":"22","author":"N Sharma","year":"2016","unstructured":"Sharma N, Akhade AS, Qadri A (2016) Src kinases central to T-cell receptor signaling regulate TLR-activated innate immune responses from human T cells. Innate Immun 22:238\u2013244. https:\/\/doi.org\/10.1177\/1753425916632305","journal-title":"Innate Immun"},{"key":"12455_CR55","doi-asserted-by":"publisher","first-page":"e51243","DOI":"10.1371\/journal.pone.0051243","volume":"8","author":"MY Peroval","year":"2013","unstructured":"Peroval MY, Boyd AC, Young JR, Smith AL (2013) A Critical Role for MAPK Signalling Pathways in the Transcriptional Regulation of Toll Like Receptors. PLoS ONE 8:e51243. https:\/\/doi.org\/10.1371\/journal.pone.0051243","journal-title":"PLoS ONE"},{"key":"12455_CR56","doi-asserted-by":"publisher","first-page":"11388","DOI":"10.1038\/s41598-020-68219-4","volume":"10","author":"A Shrestha","year":"2020","unstructured":"Shrestha A, Bruckmueller H, Kildalsen H et al (2020) Phosphorylation of steroid receptor coactivator-3 (SRC-3) at serine 857 is regulated by the p38MAPK-MK2 axis and affects NF-\u03baB-mediated transcription. Sci Rep 10:11388. https:\/\/doi.org\/10.1038\/s41598-020-68219-4","journal-title":"Sci Rep"},{"key":"12455_CR57","doi-asserted-by":"publisher","unstructured":"Scior T, M. Domeyer D, Cuanalo-Contreras K, A. Laufer S (2011) Pharmacophore Design of p38\u03b1 MAP Kinase Inhibitors with Either 2,4,5-Trisubstituted or 1,2,4,5-Tetrasubstituted Imidazole Scaffold. Curr Med Chem 18:1526\u20131539. https:\/\/doi.org\/10.2174\/092986711795328409","DOI":"10.2174\/092986711795328409"},{"key":"12455_CR58","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1016\/j.bmcl.2005.08.038","volume":"15","author":"EL Michelotti","year":"2005","unstructured":"Michelotti EL, Moffett KK, Nguyen D et al (2005) Two classes of p38\u03b1 MAP kinase inhibitors having a common diphenylether core but exhibiting divergent binding modes. Bioorg Med Chem Lett 15:5274\u20135279. https:\/\/doi.org\/10.1016\/j.bmcl.2005.08.038","journal-title":"Bioorg Med Chem Lett"},{"key":"12455_CR59","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1021\/jm801467h","volume":"52","author":"BA Thaher","year":"2009","unstructured":"Thaher BA, Koch P, Schattel V, Laufer S (2009) Role of the Hydrogen Bonding Heteroatom\u2013Lys53 Interaction between the p38\u03b1 Mitogen-Activated Protein (MAP) Kinase and Pyridinyl-Substituted 5-Membered Heterocyclic Ring Inhibitors. J Med Chem 52:2613\u20132617. https:\/\/doi.org\/10.1021\/jm801467h","journal-title":"J Med Chem"},{"key":"12455_CR60","doi-asserted-by":"publisher","first-page":"20677","DOI":"10.1074\/jbc.M110.213736","volume":"286","author":"S Eathiraj","year":"2011","unstructured":"Eathiraj S, Palma R, Hirschi M et al (2011) A Novel Mode of Protein Kinase Inhibition Exploiting Hydrophobic Motifs of Autoinhibited Kinases. J Biol Chem 286:20677\u201320687. https:\/\/doi.org\/10.1074\/jbc.M110.213736","journal-title":"J Biol Chem"},{"key":"12455_CR61","doi-asserted-by":"publisher","unstructured":"Mishra SVS, Sharma SK, Georrge K JJ (2023) Designing of a novel curcumin analogue to inhibit mitogen-activated protein kinase: A cheminformatics approach. J Phytonanotechnology Pharm Sci 3. https:\/\/doi.org\/10.54085\/jpps.2023.3.1.5","DOI":"10.54085\/jpps.2023.3.1.5"},{"key":"12455_CR62","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1021\/acs.jcim.7b00640","volume":"58","author":"W You","year":"2018","unstructured":"You W, Chang CA (2018) Role of Molecular Interactions and Protein Rearrangement in the Dissociation Kinetics of p38\u03b1 MAP Kinase Type-I\/II\/III Inhibitors. J Chem Inf Model 58:968\u2013981. https:\/\/doi.org\/10.1021\/acs.jcim.7b00640","journal-title":"J Chem Inf Model"},{"key":"12455_CR63","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1016\/j.bpj.2021.08.026","volume":"120","author":"YM Huang","year":"2021","unstructured":"Huang YM (2021) Multiscale computational study of ligand binding pathways: Case of p38 MAP kinase and its inhibitors. Biophys J 120:3881\u20133892. https:\/\/doi.org\/10.1016\/j.bpj.2021.08.026","journal-title":"Biophys J"},{"key":"12455_CR64","doi-asserted-by":"publisher","first-page":"124853","DOI":"10.1016\/j.ijbiomac.2023.124853","volume":"242","author":"MR Amiran","year":"2023","unstructured":"Amiran MR, Taghdir M, Abasi Joozdani F (2023) Molecular insights into the behavior of the allosteric and ATP-competitive inhibitors in interaction with AKT1 protein: A molecular dynamics study. Int J Biol Macromol 242:124853. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.124853","journal-title":"Int J Biol Macromol"},{"key":"12455_CR65","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1039\/C2MB25042J","volume":"8","author":"Y Yang","year":"2012","unstructured":"Yang Y, Liu H, Yao X (2012) Understanding the molecular basis of MK2\u2013p38\u03b1 signaling complex assembly: insights into protein\u2013protein interaction by molecular dynamics and free energy studies. Mol Biosyst 8:2106\u20132118. https:\/\/doi.org\/10.1039\/C2MB25042J","journal-title":"Mol Biosyst"},{"key":"12455_CR66","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/bbb\/zbae091","volume":"88","author":"RC Yanagita","year":"2024","unstructured":"Yanagita RC, Suzuki Y, Kawanami Y et al (2024) Effect of phenolic-hydroxy-group incorporation on the biological activity of a simplified aplysiatoxin analog with an (R)-(\u2013)-carvone-based core. Biosci Biotechnol Biochem 88:992\u2013998. https:\/\/doi.org\/10.1093\/bbb\/zbae091","journal-title":"Biosci Biotechnol Biochem"},{"key":"12455_CR67","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/biom10010138","volume":"10","author":"SK Liew","year":"2020","unstructured":"Liew SK, Malagobadan S, Arshad NM, Nagoor NH (2020) A Review of the Structure\u2013Activity Relationship of Natural and Synthetic Antimetastatic Compounds. Biomolecules 10:138. https:\/\/doi.org\/10.3390\/biom10010138","journal-title":"Biomolecules"},{"key":"12455_CR68","doi-asserted-by":"publisher","unstructured":"Zoatier B, Gizem Yildiztekin K, Abdullah Alagoz M et al (2025) Development of Potent Type V MAPK Inhibitors: Design, Synthesis, and Biological Evaluation of Benzothiazole Derivatives Targeting p38\u03b1 MAPK in Breast Cancer Cells. Arch Pharm (Weinheim) 358. https:\/\/doi.org\/10.1002\/ardp.202500011","DOI":"10.1002\/ardp.202500011"},{"key":"12455_CR69","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1021\/acsmedchemlett.5b00126","volume":"6","author":"M Rosa","year":"2015","unstructured":"Rosa M, Caltabiano G, Barreto-Valer K et al (2015) Modulation of the Interaction between a Peptide Ligand and a G Protein-Coupled Receptor by Halogen Atoms. ACS Med Chem Lett 6:872\u2013876. https:\/\/doi.org\/10.1021\/acsmedchemlett.5b00126","journal-title":"ACS Med Chem Lett"},{"key":"12455_CR70","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.3390\/molecules29122800","volume":"29","author":"S Alagawani","year":"2024","unstructured":"Alagawani S, Vasilyev V, Clayton AHA, Wang F (2024) Insights into Halogen-Induced Changes in 4-Anilinoquinazoline EGFR Inhibitors: A Computational Spectroscopic Study. Molecules 29:2800. https:\/\/doi.org\/10.3390\/molecules29122800","journal-title":"Molecules"},{"key":"12455_CR71","doi-asserted-by":"publisher","unstructured":"Gai C, Zhang Y, Zhang S et al (2024) The study of halogen effect on the reactivity of the serine-targeting covalent warheads. Front Chem 12. https:\/\/doi.org\/10.3389\/fchem.2024.1504453","DOI":"10.3389\/fchem.2024.1504453"},{"key":"12455_CR72","first-page":"3755","volume":"11","author":"G Kaur","year":"2021","unstructured":"Kaur G, Kaur M, Bansal M (2021) New insights of structural activity relationship of curcumin and correlating their efficacy in anticancer studies with some other similar molecules. Am J Cancer Res 11:3755\u20133765","journal-title":"Am J Cancer Res"},{"key":"12455_CR73","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1042\/CS20160935","volume":"131","author":"AB Kunnumakkara","year":"2017","unstructured":"Kunnumakkara AB, Bordoloi D, Harsha C et al (2017) Curcumin mediates anticancer effects by modulating multiple cell signaling pathways. Clin Sci 131:1781\u20131799. https:\/\/doi.org\/10.1042\/CS20160935","journal-title":"Clin Sci"},{"key":"12455_CR74","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.13005\/ojc\/330503","volume":"33","author":"Y Eryanti","year":"2017","unstructured":"Eryanti Y, Zamri A, Frimayanti N et al (2017) Synthesis, Structure-Activity Relationship, Docking and Molecular Dynamic Simulation of Curcumin Analogues Against HL-60 for Anti Cancer Agents (Leukemia). Orient J Chem 33:2164\u20132172. https:\/\/doi.org\/10.13005\/ojc\/330503","journal-title":"Orient J Chem"},{"key":"12455_CR75","doi-asserted-by":"publisher","unstructured":"Ferkany JW (2006) Pharmacokinetics. Curr Protoc Pharmacol 34. https:\/\/doi.org\/10.1002\/0471141755.ph0700s34","DOI":"10.1002\/0471141755.ph0700s34"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12455-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12455-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12455-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:06:56Z","timestamp":1785823616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12455-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12455"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12455-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures involving the SKOV-3 cell line were performed in strict accordance with institutional ethical regulations and were approved by the Medical and Health Research Ethics Committee of the Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia (Approval No. KE\/FK\/0495\/EC\/2023).","order":3,"name":"Ethics","label":"Ethical consideration","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1328"}}